66 related articles for article (PubMed ID: 7912665)
1. Perioperative Chemotherapy for Pancreas Cancer: Quo Vadis?
Patel RK; Rocha FG
Ann Surg Oncol; 2024 Jul; 31(7):4176-4178. PubMed ID: 38652201
[No Abstract] [Full Text] [Related]
2. Desmoplastic reaction influences pancreatic cancer growth behavior.
Hartel M; Di Mola FF; Gardini A; Zimmermann A; Di Sebastiano P; Guweidhi A; Innocenti P; Giese T; Giese N; Büchler MW; Friess H
World J Surg; 2004 Aug; 28(8):818-25. PubMed ID: 15457365
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis: targets in pancreatic cancer.
Westphal S; Kalthoff H
Mol Cancer; 2003 Jan; 2():6. PubMed ID: 12605713
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant, adjuvant, and palliative treatment of pancreatic cancer.
Birk D; Beger HG
Curr Gastroenterol Rep; 2001 Apr; 3(2):129-35. PubMed ID: 11276380
[TBL] [Abstract][Full Text] [Related]
5. Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas.
Meyer W; Jurowich C; Reichel M; Steinhäuser B; Wünsch PH; Gebhardt C
Surg Today; 2000; 30(7):582-7. PubMed ID: 10930222
[TBL] [Abstract][Full Text] [Related]
6. Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer.
Friess H; Lu Z; Andrén-Sandberg A; Berberat P; Zimmermann A; Adler G; Schmid R; Büchler MW
Ann Surg; 1998 Dec; 228(6):780-7. PubMed ID: 9860477
[TBL] [Abstract][Full Text] [Related]
7. Celiac artery adjuvant chemotherapy. Results of a prospective trial.
Link KH; Gansauge F; Rilinger N; Beger HG
Int J Pancreatol; 1997 Feb; 21(1):65-9. PubMed ID: 9127176
[TBL] [Abstract][Full Text] [Related]
8. Molecular oncology in pancreatic cancer.
Gansauge S; Gansauge F; Beger HG
J Mol Med (Berl); 1996 Jun; 74(6):313-20. PubMed ID: 8862512
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy following resection for pancreatic adenocarcinoma.
Brennan MF
Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
[TBL] [Abstract][Full Text] [Related]
10. [Surgical results and indications for adjuvant measures in pancreatic cancer].
Beger HG; Büchler MW; Friess H
Chirurg; 1994 Apr; 65(4):246-52. PubMed ID: 7912665
[No Abstract] [Full Text] [Related]
11. [Pancreatic cancer--treatment].
Pistorius GA; Schilling MK
Dtsch Med Wochenschr; 2002 Nov; 127(44):2330-2. PubMed ID: 12410437
[No Abstract] [Full Text] [Related]
12. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
Zhu AX; Clark JW; Willett CG
Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
[TBL] [Abstract][Full Text] [Related]
13. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Ghaneh P; Neoptolemos JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for pancreatic cancer: current status and future directions.
Xiong HQ; Abbruzzese JL
Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
